PVP — Evervie Health Share Price
Last trade - 00:00- IN₹10.34bn
- IN₹14.19bn
- IN₹897.11m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.74 | ||
| Price to Tang. Book | 279.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.76 | ||
| EV to EBITDA | 101.84 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.75% | ||
| Return on Equity | 2.27% | ||
| Operating Margin | -4.11% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 487.62 | 1,756.77 | 84.73 | 272.03 | 897.11 | n/a | n/a | 38.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +43.53 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Evervie Health Limited, formerly PVP Ventures Limited, is an India-based healthcare platform with operating businesses in renal care, cancer care and diagnostics. The Company also operates a legacy real-estate portfolio. The Company's segments include Real Estate and Health Care Services. The Company's subsidiaries include PVP Corporate Parks Private Limited, Humain Healthtech Private Limited, Biohygea Global Private Limited, Optimus Oncology Private Limited, and 7Med India Private Limited. Optimus Oncology Private Limited collaborates with local hospitals to set up Oncology Centres within these partner hospitals. Biohygea Global Private Limited operates under the brand name Medilabs. Humain Sai Labs is a diagnostics center based out of Chennai servicing key locations in South Chennai. Services include lab tests, Ultrasound and X Ray. 7Med India Private Limited is a hospital-partnered dialysis network addressing renal care need.
Directors
- Prasad Potluri CHM (50)
- S. Rukmani CCO
- Sai Potluri EDR
- P. Bhavani NED
- Subramanian Parameswaran NED
- Sohrab Kersasrp IND (65)
- N. Kumar NID (69)
- R. Nagarajan NID (74)
- Nandakumar Subburaman NID
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- January 1st, 1991
- Public Since
- March 23rd, 2000
- No. of Shareholders
- 46,658
- No. of Employees
- 20
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 260,403,681
- Address
- Plot No. 83 & 84 4th Floor, HYDERABAD, 500034
- Web
- https://www.pvpglobal.com
- Phone
- +91 4067309999
- Auditors
- M/s PSDY & Associates
Latest News for PVP
Upcoming Events for PVP
Q2 2027 PVP Ventures Ltd Earnings Release
Q3 2027 PVP Ventures Ltd Earnings Release
Similar to PVP
Aakaar Medical Technologies
National Stock Exchange of India
Aatmaj Healthcare
National Stock Exchange of India
ABH Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
FAQ
As of Today at 22:49 UTC, shares in Evervie Health are trading at IN₹39.72. This share price information is delayed by 15 minutes.
Shares in Evervie Health last closed at IN₹39.72 and the price had moved by +28.54% over the past 365 days. In terms of relative price strength the Evervie Health share price has outperformed the S&P BSE 100 Index by +44.82% over the past year.
There is no consensus recommendation for this security.
Find out moreEvervie Health does not currently pay a dividend.
Evervie Health does not currently pay a dividend.
Evervie Health does not currently pay a dividend.
To buy shares in Evervie Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹39.72, shares in Evervie Health had a market capitalisation of IN₹10.34bn.
Here are the trading details for Evervie Health:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: PVP
Based on an overall assessment of its quality, value and momentum Evervie Health is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Evervie Health. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +27.78%.
As of the last closing price of IN₹39.72, shares in Evervie Health were trading +11.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Evervie Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹39.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Evervie Health's management team is headed by:
- Prasad Potluri - CHM
- S. Rukmani - CCO
- Sai Potluri - EDR
- P. Bhavani - NED
- Subramanian Parameswaran - NED
- Sohrab Kersasrp - IND
- N. Kumar - NID
- R. Nagarajan - NID
- Nandakumar Subburaman - NID